Adaptive Biotechnologies
Trade Adaptive Biotechnologies 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ADPT
Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines.
ADPT Key Statistics
Stock Snapshot
The current Adaptive Biotechnologies(ADPT) stock price is $28.06, with a market capitalization of 4.48B. The stock trades at a price-to-earnings (P/E) ratio of -68.30.
On 2026-09-22, Adaptive Biotechnologies(ADPT) stock traded between a low of $26.50 and a high of $28.36. Shares are currently priced at $28.06, which is +5.9% above the low and -1.0% below the high.
The Adaptive Biotechnologies(ADPT)'s current trading volume is 4M, compared to an average daily volume of 2.34M.
In the last year, Adaptive Biotechnologies(ADPT) shares hit a 52-week high of $28.78 and a 52-week low of $12.00.
In the last year, Adaptive Biotechnologies(ADPT) shares hit a 52-week high of $28.78 and a 52-week low of $12.00.
ADPT News
BTIG raised the firm’s price target on Adaptive Biotechnologies (ADPT) to $34 from $25 and keeps a Buy rating on the shares. The firm notes that the NCCN update...
Advertisement Clinical guideline update puts Adaptive Biotechnologies in focus Adaptive Biotechnologies (ADPT) moved into the spotlight after the National Com...
...
Analyst ratings
88%
of 8 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.